Saturday 17 October 2026
Export SNN’s income statement to Excel — free account
Smith & Nephew SNATS, Inc.
SNN Healthcare Medical Devices
Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024. Revenue growth for five consecutive years, operating cash flow growth for three.
29.06
0.03
−0.10%
Follow SNN
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
26.63 | 30.99 | 30.51 | 32.50 | 34.97 | 30.83 | 31.96 | 32.73 | 29.96 | 39.99 |
Piotroski F-Score |
7 | 7 | 6 | 4 | 4 | 7 | 8 | 7 | 7 | 7 |
P/S ratio |
2.92 | 3.40 | 2.81 | 2.43 | 1.92 | 1.58 | 1.19 | 1.15 | 1.05 | 1.40 |
Altman Z-Score |
4.32 | 4.83 | 5.08 | 4.82 | 3.39 | 3.28 | 3.13 | 3.09 | 3.05 | 3.49 |
Altman Z″-Score (non-manufacturers) |
4.78 | 5.26 | 5.51 | 4.75 | 4.39 | 4.39 | 4.53 | 4.19 | 4.92 | 4.82 |
P/FCF ratio |
8.21 | 7.78 | 10.57 | 12.27 | 13.21 | 15.05 | 15.31 | 44.53 | 13.83 | 8.05 |
Beneish M-Score |
(2.45) | (2.58) | (2.61) | (2.77) | (2.86) | (2.55) | (2.59) | (2.64) | (2.70) | (2.70) |
P/Operating CF |
44.63 | 51.94 | 55.63 | 71.54 | 62.76 | 51.52 | 40.61 | 39.96 | 36.58 | 48.83 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 61 |
P/B ratio |
3.41 | 3.38 | 3.45 | 4.20 | 3.59 | 2.79 | 2.33 | 2.31 | 2.10 | 2.79 |
Price to Tangible BV |
37.54 | 17.39 | 12.66 | 27.52 | 21.91 | 13.17 | 12.36 | 10.82 | 9.15 | 11.35 |
EV/Sales |
3.24 | 3.67 | 2.97 | 2.62 | 2.09 | 1.74 | 1.42 | 1.34 | 1.30 | 1.65 |
EV/EBITDA |
12.58 | 14.26 | 11.40 | 9.82 | 8.65 | 7.21 | 5.60 | 5.47 | 5.32 | 6.75 |
EV/Operating CF |
5.59 | 5.10 | 6.65 | 8.18 | 7.82 | 7.61 | 7.64 | 10.09 | 7.03 | 5.98 |
EV/FCF |
9.10 | 8.40 | 11.15 | 13.23 | 14.32 | 16.55 | 18.26 | 51.97 | 17.13 | 9.48 |
Quick Ratio |
0.95 | 1.06 | 1.15 | 1.03 | 1.76 | 1.21 | 0.96 | 0.72 | 1.33 | 1.25 |
Current Ratio |
1.88 | 2.03 | 2.10 | 2.06 | 2.76 | 2.08 | 2.25 | 1.77 | 2.89 | 2.57 |
Net Debt/EBITDA |
1.16 | 0.91 | 0.72 | 1.29 | 1.86 | 1.34 | 2.21 | 1.82 | 2.03 | 1.92 |
Debt/Assets |
21.30% | 18.09% | 16.14% | 21.24% | 30.45% | 26.08% | 27.21% | 23.22% | 31.47% | 30.38% |
Debt/Equity |
0.40 | 0.31 | 0.27 | 0.38 | 0.64 | 0.51 | 0.52 | 0.44 | 0.62 | 0.60 |
Asset Turnover |
0.64 | 0.63 | 0.62 | 0.59 | 0.45 | 0.48 | 0.50 | 0.56 | 0.57 | 0.59 |
Operating CF/Net income |
1.08 | 1.42 | 1.40 | 1.95 | 2.09 | 1.67 | 2.10 | 2.31 | 2.40 | 2.06 |
Capex/Depreciation |
(0.85) | (0.84) | (0.80) | (0.81) | (0.79) | (0.72) | (0.58) | (0.63) | (0.59) | (0.69) |
Interest Coverage |
15.40 | 16.39 | 14.63 | 12.54 | 4.76 | 7.41 | 5.63 | 3.22 | 4.53 | 5.67 |
| 19.79% | 17.83% | 13.93% | 11.98% | 8.60% | 9.66% | 4.12% | 5.02% | 7.86% | 11.84% | |
| 10.81% | 10.09% | 8.33% | 6.91% | 4.41% | 4.78% | 2.14% | 2.64% | 4.05% | 6.01% | |
ROIC |
9.23% | 9.90% | 9.28% | 7.45% | 2.68% | 5.20% | 3.69% | 3.67% | 5.20% | 6.27% |
Return on Tangible Assets |
36.25% | 31.51% | 24.79% | 20.15% | 10.12% | 13.77% | 6.20% | 8.14% | 9.55% | 15.07% |
Average Days of Receivables |
92.64 | 96.36 | 98.02 | 94.34 | 96.93 | 90.34 | 91.06 | 87.68 | 88.89 | 84.62 |
Research and Development Expense of Revenue |
4.93% | 4.68% | 5.02% | 5.68% | 6.73% | 6.83% | 6.62% | 6.11% | 4.97% | 4.80% |
Selling, General and Administrative Expense of Revenue |
50.67% | 49.53% | 50.92% | 52.41% | 56.18% | 52.19% | 55.23% | 55.05% | 53.36% | 50.32% |
Intangible Assets out of Total Assets |
0.49 | 0.48 | 0.44 | 0.47 | 0.40 | 0.40 | 0.43 | 0.41 | 0.39 | 0.38 |
Share Based Compensation of Revenue |
0.58% | 0.65% | 0.71% | 0.62% | 0.57% | 0.79% | 0.77% | 0.70% | 0.69% | 0.70% |
Graham Net Nets |
(0.06) | (0.03) | (0.01) | (0.04) | (0.06) | (0.06) | (0.07) | (0.06) | (0.06) | (0.07) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.75% | 3.23% | 3.28% | 3.08% | 2.86% | 3.24% | 3.13% | 3.06% | 3.34% | 2.50% |
Free Cash Flow Yield |
12.18% | 12.85% | 9.46% | 8.15% | 7.57% | 6.65% | 6.53% | 2.25% | 7.23% | 12.42% |
Revenue per Share |
10.49 | 10.90 | 11.23 | 11.76 | 10.42 | 11.89 | 11.96 | 12.74 | 13.31 | 14.22 |
Operating CF per Share |
1.91 | 2.49 | 2.13 | 2.67 | 2.14 | 2.00 | 1.07 | 1.40 | 2.26 | 2.96 |
Capex per Share |
(0.88) | (0.86) | (0.79) | (0.93) | (1.01) | (0.93) | (0.82) | (0.98) | (0.87) | (0.91) |
Free Cash Flow per Share |
1.03 | 1.63 | 1.34 | 1.74 | 1.12 | 1.07 | 0.25 | 0.42 | 1.39 | 2.05 |
Cash per Share |
0.22 | 0.39 | 0.84 | 0.63 | 4.03 | 2.94 | 0.80 | 0.69 | 1.42 | 1.28 |
Shareholders Equity per Share |
8.89 | 10.63 | 11.17 | 11.76 | 12.07 | 12.70 | 12.06 | 11.98 | 12.06 | 12.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.89 | 10.63 | 11.17 | 11.76 | 12.07 | 12.70 | 12.06 | 11.98 | 12.06 | 12.20 |
Free Cash Flow |
457.00 | 714.00 | 584.00 | 760.00 | 492.00 | 469.00 | 110.00 | 181.00 | 606.00 | 890.00 |
Working Capital |
1,181.00 | 1,385.00 | 1,612.00 | 1,655.00 | 2,976.00 | 2,293.00 | 2,141.00 | 1,759.00 | 2,890.00 | 2,508.00 |
Capital Expenditures |
(392.00) | (376.00) | (347.00) | (408.00) | (443.00) | (408.00) | (358.00) | (427.00) | (381.00) | (395.00) |
Net Current Asset Value |
(857.00) | (491.00) | (108.00) | (939.00) | (1,069.00) | (928.00) | (851.00) | (740.00) | (668.00) | (1,065.00) |
EV/EBIT |
19.95 | 22.62 | 23.68 | 31.11 | 27.43 | 22.85 | 19.53 | 18.80 | 18.27 | 23.19 |
Capex to Sales |
0.08 | 0.08 | 0.07 | 0.08 | 0.10 | 0.08 | 0.07 | 0.08 | 0.07 | 0.06 |
Price to Operating Income |
18.00 | 20.94 | 22.43 | 28.84 | 25.30 | 20.77 | 16.38 | 16.11 | 14.75 | 19.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.47 | 0.43 | 0.41 | 0.38 | 0.39 | 0.37 | 0.42 | 0.46 | 0.45 | 0.35 |
Cash ROIC |
8.13% | 11.45% | 8.93% | 10.28% | 4.73% | 4.83% | 1.32% | 2.31% | 6.63% | 9.86% |
Accounts Receivable Turnover |
4.02 | 3.90 | 3.81 | 3.89 | 3.59 | 4.17 | 4.03 | 4.21 | 4.23 | 4.33 |
Accounts Payable Turnover |
1.47 | 1.36 | 1.36 | 1.34 | 1.35 | 1.46 | 1.40 | 1.61 | 1.62 | 1.71 |
Inventory Turnover |
1.03 | 0.98 | 0.96 | 0.89 | 0.84 | 0.87 | 0.76 | 0.75 | 0.74 | 0.88 |
Average Days of Payables |
253.66 | 279.89 | 269.11 | 285.34 | 267.21 | 259.26 | 260.24 | 222.59 | 233.40 | 217.85 |
Days of Inventory on Hand |
356.97 | 381.38 | 392.28 | 440.29 | 442.13 | 436.20 | 522.61 | 505.30 | 493.91 | 391.84 |
Average Receivables |
1,161.50 | 1,221.50 | 1,287.50 | 1,322.50 | 1,269.50 | 1,250.50 | 1,295.50 | 1,317.00 | 1,374.00 | 1,422.00 |
Average Payables |
863.00 | 920.50 | 957.00 | 1,001.50 | 1,034.00 | 1,059.00 | 1,097.00 | 1,076.50 | 1,091.50 | 1,152.50 |
Average Inventory |
1,230.50 | 1,274.00 | 1,349.50 | 1,504.50 | 1,652.50 | 1,767.50 | 2,024.50 | 2,300.00 | 2,391.00 | 2,252.00 |
Average Assets |
7,255.50 | 7,605.00 | 7,962.50 | 8,679.00 | 10,155.50 | 10,966.00 | 10,443.00 | 9,976.50 | 10,170.50 | 10,405.50 |
Average Common Equity |
3,962.00 | 4,301.00 | 4,759.00 | 5,007.50 | 5,210.00 | 5,423.50 | 5,413.50 | 5,238.00 | 5,241.00 | 5,277.00 |
Columns are period end dates